0001104659-20-020237.txt : 20200213 0001104659-20-020237.hdr.sgml : 20200213 20200213163203 ACCESSION NUMBER: 0001104659-20-020237 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200212 FILED AS OF DATE: 20200213 DATE AS OF CHANGE: 20200213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vazzano Joseph Walter CENTRAL INDEX KEY: 0001715291 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38114 FILM NUMBER: 20611169 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001644963 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474113275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 4 1 tm208004-2_form4.xml FORM 4 X0306 4 2020-02-12 0 0001644963 AVENUE THERAPEUTICS, INC. ATXI 0001715291 Vazzano Joseph Walter 1140 AVENUE OF THE AMERICAS, FLOOR 9 NEW YORK NY 10036 0 1 0 0 Chief Financial Officer Restricted Stock Units 0.00 2020-02-12 4 A 0 22727 0.00 A 2025-02-12 Common Stock 22727 50505 D Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen. /s/ Joseph Vazzano 2020-02-13